SELECT MEDICAL HOLDINGS CORP - Common Stock (SEM)
CUSIP: 81619Q105
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 124,068,451
- Total 13F shares
- 100,467,489
- Share change
- -5,708,701
- Total reported value
- $1,525,083,959
- Price per share
- $15.18
- Number of holders
- 261
- Value change
- -$89,875,058
- Number of buys
- 142
- Number of sells
- 128
Quarterly Holders Quick Answers
What is CUSIP 81619Q105?
CUSIP 81619Q105 identifies SEM - SELECT MEDICAL HOLDINGS CORP - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 81619Q105:
Top shareholders of SEM - SELECT MEDICAL HOLDINGS CORP - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
12%
from 13D/G
|
20,130,017
|
$336,171,277 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
14%
|
17,755,298
|
$296,515,000 | — | 31 Mar 2025 | |
| Rocco A. Ortenzio |
3/4/5
13D/G
|
CHAIRMAN EMERITUS & CO-FOUNDER · Estate of Rocco A. Ortenzio |
3.2%
from 13D/G
|
7,890,355
|
$269,692,334 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
11%
|
13,316,069
|
$222,378,352 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
3.4%
|
4,215,663
|
$70,401,368 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
3.4%
|
4,198,107
|
$70,108,387 | — | 31 Mar 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
3.2%
|
4,029,944
|
$67,301,000 | — | 31 Mar 2025 | |
| Hood River Capital Management LLC |
13F
|
Company |
2.4%
|
3,017,029
|
$50,384,384 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
2,954,761
|
$49,354,241 | — | 31 Mar 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
2%
|
2,476,816
|
$41,362,843 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.4%
|
1,712,991
|
$28,606,950 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1.3%
|
1,633,877
|
$27,285,746 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
1.2%
|
1,534,381
|
$25,624,163 | — | 31 Mar 2025 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
1.2%
|
1,507,349
|
$25,172,728 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.2%
|
1,459,894
|
$24,380,232 | — | 31 Mar 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.2%
|
1,449,805
|
$24,211,742 | — | 31 Mar 2025 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
1.1%
|
1,417,449
|
$23,671,398 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.1%
|
1,343,768
|
$22,440,933 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.1%
|
1,314,843
|
$21,957,878 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.95%
|
1,175,041
|
$19,623,216 | — | 31 Mar 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.86%
|
1,068,658
|
$17,846,589 | — | 31 Mar 2025 | |
| Bryan C. Cressey |
3/4/5
|
Director |
—
class O/S missing
|
528,885
|
$14,084,208 | — | 01 Aug 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.59%
|
728,689
|
$12,169,103 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.59%
|
726,556
|
$12,133,485 | — | 31 Mar 2025 | |
| Empowered Funds, LLC |
13F
|
Company |
0.49%
|
613,801
|
$10,250,477 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.46%
|
573,307
|
$9,574,227 | — | 31 Mar 2025 | |
| Russell L. Carson |
3/4/5
|
Director |
0.49%
|
610,035
|
$9,040,718 | — | 29 Apr 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.43%
|
530,164
|
$8,853,739 | — | 31 Mar 2025 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.42%
|
522,767
|
$8,730,000 | — | 31 Mar 2025 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.32%
|
401,355
|
$6,702,628 | — | 31 Mar 2025 | |
| First Eagle Investment Management, LLC |
13F
|
Company |
0.31%
|
381,159
|
$6,365,355 | — | 31 Mar 2025 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.31%
|
380,809
|
$6,359,509 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.29%
|
358,072
|
$5,979,803 | — | 31 Mar 2025 | |
| Baird Financial Group, Inc. |
13F
|
Company |
0.27%
|
339,598
|
$5,671,287 | — | 31 Mar 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.27%
|
337,051
|
$5,628,752 | — | 31 Mar 2025 | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD |
13F
|
Company |
0.27%
|
331,385
|
$5,534,130 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.26%
|
328,300
|
$5,482,610 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.26%
|
328,255
|
$5,481,860 | — | 31 Mar 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.26%
|
323,968
|
$5,410,266 | — | 31 Mar 2025 | |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.26%
|
320,450
|
$5,351,515 | — | 31 Mar 2025 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.26%
|
317,295
|
$5,298,826 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.25%
|
312,366
|
$5,216,491 | — | 31 Mar 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.25%
|
305,500
|
$5,101,838 | — | 31 Mar 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.24%
|
302,519
|
$5,052,071 | — | 31 Mar 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.24%
|
298,485
|
$4,984,701 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.23%
|
284,463
|
$4,750,529 | — | 31 Mar 2025 | |
| Scott A. Romberger |
3/4/5
|
SENIOR VICE PRESIDENT |
—
class O/S missing
|
174,087
|
$4,635,937 | — | 31 Oct 2022 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.22%
|
277,525
|
$4,634,668 | — | 31 Mar 2025 | |
| Dana Investment Advisors, Inc. |
13F
|
Company |
0.22%
|
276,527
|
$4,618,001 | — | 31 Mar 2025 | |
| Foundry Partners, LLC |
13F
|
Company |
0.22%
|
276,156
|
$4,611,805 | — | 31 Mar 2025 |
Institutional Holders of SELECT MEDICAL HOLDINGS CORP - Common Stock (SEM) as of Q2 2025
As of 30 Jun 2025,
SELECT MEDICAL HOLDINGS CORP - Common Stock (SEM) was held by
261 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
100,467,489 shares.
The largest 10 holders included
BlackRock, Inc., PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, T. Rowe Price Investment Management, Inc., GEODE CAPITAL MANAGEMENT, LLC, PRINCIPAL FINANCIAL GROUP INC, 8 KNOTS MANAGEMENT, LLC, and Hood River Capital Management LLC.
This page lists
261
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
272
Q2 2025 holders
261
Holder diff
-11
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.